Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PA101 (inhaled cromolyn sodium) for chronic idiopathic cough and cough in idiopathic pulmonary fibrosis
2014-004025-40Phase 2Active
- Sponsor
- Patara Pharma
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of sodium cromoglycate in chronic idiopathic cough (CIC) and idiopathic pulmonary fibrosis (IPF), sponsored by Patara Pharma. Primary endpoint: Cough efficacy. Started Dec 2014; status: active.
02
Drugs
sodium cromoglycate
03
Conditions
chronic idiopathic cough (CIC)idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on 2014-004025-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004025-40.